Physician profile
William D Altig
NPI 1538251285
$4,110.05
in general payments reported to CMS, 2019-2025
16 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $368 · 2021: $393 · 2022: $974 · 2023: $776 · 2024: $778 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,701.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,634.86 | 2019-2024 | Acuvue |
| Coopervision INC. | $371.65 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Sun Pharmaceutical Industries INC. | $346.78 | 2022-2024 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $337.09 | 2019-2020 | |
| Glaukos Corporation | $235.79 | 2019 | |
| Biotissue Holdings INC. | $213.14 | 2019-2025 | |
| Carl Zeiss Meditec USA, INC. | $200.26 | 2022-2024 | Cirrus Hd-Oct |
| Carl Zeiss Meditec, INC. | $159.32 | 2020 | |
| Bausch & Lomb Americas INC. | $143.77 | 2024 | Miebo, Xiidra, Infuse |
| Tarsus Pharmaceuticals, INC. | $143.23 | 2024 | Xdemvy |
| Dompe US, INC. | $124.99 | 2023 | Oxervate |
| Alcon Vision LLC | $90.51 | 2021-2024 | |
| Lensar, INC. | $59.66 | 2020 | |
| Shire North American Group INC | $19.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.93 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $14.69 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Altig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.